RXcelebs
 
877-RX-CELEBS info@rxcelebs.com REQUEST MORE INFO
   
HOME WHO WE ARE WHAT MAKES US UNIQUE OUR SERVICES OUR CLIENTS OUR WORK INDUSTRY NEWS
 
CONTACT US
 
Home > NewsIndustry News > Healthcare Updates
  Pharma Television News
Changing Relationships, PTV News: Jun 04, 2010
How big pharma and biotechs are adapting to changing times
Glaxo Study, PTV News: Jun 04, 2010
Report says lower doses of diabetes drug work while cutting heart attack risks
Sanofi Deal, PTV News: Jun 04, 2010
French pharma giant in US$ 398M pre-clinical cancer agreement with Ascenta
News Headlines, PTV News: Jun 04, 2010
Today's forthcoming news stories: sanofi signs US$ 398M pre-clinical cancer deal; Glaxo says lower doses of Avandia cut heart attack risk; and expert insight on the changing relationship between big pharma and biotechs
Parkinson Partners, PTV News: Jun 03, 2010
Biovail and Kyowa Hakko Kirin hook up in drug development deal
France Cuts, PTV News: Jun 03, 2010
Pricing pressures as French government seeks cheaper drugs and pharma giants agree to slash AIDS treatments
Novartis Trials, PTV News: Jun 03, 2010
Positive stage III results for treatment of pancreatic cancer
News Headlines, PTV News: Jun 03, 2010
Today's forthcoming news stories: Positive late stage trial results for Novartis’ pancreatic cancer drug; France joins European drive to slash drug costs, and Biovail in Japanese hook-up to develop ageing Parkinson’s drug
UK Biotechs, PTV News: Jun 02, 2010
The verdict from AXA Framlington’s Andy Smith
Covidien Purchase, PTV News: Jun 02, 2010
Drugs and med devices giant buys ev3 for US$ 2.6B
Amgen Advances, PTV News: Jun 02, 2010
FDA approval of osteoporosis drug fuels multi-billion dollar sales speculation
News Headlines, PTV News: Jun 02, 2010
Today's forthcoming news stories: FDA approval of Amgen’s Prolia fuels multi-billion dollar sales speculation; Covidien buys ev3 for 2.6 billion dollars; and UK biotech goes under Andy Smith’s microscope
Positive Data, PTV News: Jun 01, 2010
Tekmira technology fights killer disease
Approval Denied, PTV News: Jun 01, 2010
AstraZeneca’s hopes of new life for Nexium dashed by FDA
Novo Leads Fight, PTV News: Jun 01, 2010
Danish diabetes giant challenges Greek government over price cut decree
News Headlines, PTV News: Jun 01, 2010
Today's forthcoming news stories: Novo Nordisk and Leo reject Greek government demands for drug price cuts; AstraZeneca’s hopes of new life for Nexium dashed by FDA, and Ebola cure hopeful Tekmira reports startling success rate in primates
Perrigo Rapped, PTV News: May 28, 2010
America’s biggest OTC maker warned over metal shavings found in drugs
Roche Warning, PTV News: May 28, 2010
Swiss company says economic crisis will bring dramatic changes
Sanofi Venture, PTV News: May 28, 2010
French pharma giant teams up with Nichi-Iko to exploit Japan’s growing generics market
News Headlines, PTV News: May 28, 2010
Today's forthcoming stories: sanofi and Nichi-Iko to capitalise on Japan’s move towards cheaper drugs; Roche boss warns idling pharma it faces extinction as financial crisis forces healthcare cuts, and FDA slams Perrigo over drug manufacturing violations
Genzyme Battle, PTV News: May 27, 2010
Billionaire investor says company boss should go
Indian Advance, PTV News: May 27, 2010
Piramal plans India’s first domestically developed drug
Novartis Setback, PTV News: May 27, 2010
Ovarian cancer candidate patupilone fails in phase III trials
News Headlines, PTV News: May 27, 2010
Today's forthcoming news stories: Novartis’s ovarian cancer fails in late stage trials; Piramal’s plans for India’s first domestically developed drug, and billionaire investor Carl Icahn tells Genzyme shareholders to terminate Termeer
Biotech Bonanza, PTV News: May 26, 2010
AXA Framlington fund manager’s predictions
Avila Partnership, PTV News: May 26, 2010
Clovis signs second oncology deal in first year
Curing Hep C, PTV News: May 26, 2010
Vertex’s telaprevir impresses in phase III trials
News Headlines, PTV News: May 26, 2010
Today's forthcoming news stories: Vertex’s Hep C drug hailed as “tantamount to a cure”; Clovis wins second oncology deal in its first year, and a leading fund manager predicts a golden age for biotech drugs
Spending Spree, PTV News: May 25, 2010
General Electric’s R&D program invests US$ 700M in first year
Targeting China, PTV News: May 25, 2010
Astellas hires 300 sales staff, forecasts doubled sales over five years
Gaucher App , PTV News: May 25, 2010
Shire launches iPhone application to pile pressure on Genzyme
News Headlines, PTV News: May 25, 2010
Today's forthcoming news stories: Shire unveils Gaucher app to poach patients from Genzyme; Astellas hires 300 sales staff for China and forecasts sales to double over five years, and GE’s life sciences R&D program spends US $700 million in its first year
Celldex Trials, PTV News: May 24, 2010
Misinterpreted data hits shares
Biotech Tax Breaks , PTV News: May 24, 2010
Obama unveils billion dollar scheme
New Drugs From Old, PTV News: May 24, 2010
Pfizer’s tie-up with Washington University
News Headlines, PTV News: May 24, 2010
Today's forthcoming news stories: Pfizer hands 500 drug candidates to Washington Uni to find new uses for old compounds; Obama administration unveils US $1B of biotech tax credits, and how misinterpretation of trial data sent shares on rollercoaster ride
Aspen targets Sigma, PTV News: May 21, 2010
Aspen Pharmacare makes US $1.24B offer for Australia's Sigma Pharmaceuticals
Equipment Drive, PTV News: May 21, 2010
Developing world scientists receive donated lab equipment from Seeding Labs
Abbott Acquisition, PTV News: May 21, 2010
Abbott buys Piramal's Healthcare Solutions for US $3.72B
News Headlines, PTV News: May 21, 2010
Today's forthcoming news stories: Abbott to buy Piramal Healthcare and become largest pharma-co in India; Australian Sigma Pharmaceuticals receives and considers takeover bid, and the head of Seeding Labs tells us about work to equip third world labs
GW Pharmaceuticals, PTV News: May 20, 2010
UK drug development company expects approval of cannabis based Sativex
Novartis Case, PTV News: May 20, 2010
Swiss pharma giant Novartis ordered to pay US $250M punitive damages
Generic Lipitor, PTV News: May 20, 2010
3 generic drug makers given go-ahead to launch their versions of world's best selling drug
News Headlines, PTV News: May 20, 2010
Today's forthcoming news stories: Generics makers get go-ahead to launch their versions of Lipitor in Canada; Novartis ordered to pay damages in US discrimination case, and the makers of a cannabis based MS treatment expect approval next month
RA Drug Trial, PTV News: May 19, 2010
Roche and Biogen halt development of rheumatoid arthritis treatment
€105M Deal, PTV News: May 19, 2010
Sanofi-aventis buys Polish consumer healthcare group Nepentes
South African IPO, PTV News: May 19, 2010
Life Healthcare aims to raise US $1.06B in markets' biggest IPO
News Headlines, PTV News: May 19, 2010
Today's forthcoming news stories: sanofi-aventis buys Polish consumer healthcare group Nepentes; Southern Africa's biggest ever IPO is launched, and Roche and Biogen halt development of experimental rheumatoid arthritis drug
HIV Infection , PTV News: May 18, 2010
US research suggests smallpox vaccine may boost ability to resist HIV infection
Amgen Application, PTV News: May 18, 2010
Amgen asks FDA to approve Denosumab to treat bone loss in cancer patients
NuPathe IPO, PTV News: May 18, 2010
Speciality pharma firm hopes to raise US $86.3M
News Headlines, PTV News: May 18, 2010
Today's forthcoming news stories: Speciality biotech NuPathe plans a US $86M IPO; Amgen seeks wider approval for is closely watched osteoporosis drug, and a new study assesses if the smallpox vaccine offers HIV protection
Spanish Savings, PTV News: May 17, 2010
Spain follows Greece and cuts prescription medication prices
Industry Expansion, PTV News: May 17, 2010
GlaxoSmithKline plans to double revenue from India and China
Astellas buys OSI, PTV News: May 17, 2010
US $4B deal agreed between Japanese drugmaker and US biotech
News Headlines, PTV News: May 17, 2010
Today's forthcoming news stories: Astellas agrees US $4B acquisition of OSI Pharmaceuticals; GSK is aiming to double revenue from India and China by cutting prices, and Spain becomes the latest EU country to cut prescription drug prices
Pharma Slump, PTV News: May 14, 2010
Japanese drugmakers predict a drop in profits as blockbuster drugs go off patent
Emerging Markets, PTV News: May 14, 2010
Abbott speeds-up its pharmaceutical leadership in emerging markets with a Zydus Cadila collaboration
Life Science Agreement, PTV News: May 14, 2010
The ERBI life science organisation's chief executive talks to us about the Golden Triangle's new partnership with Biocom
News Headlines, PTV News: May 14, 2010
Today's forthcoming news stories: Abbott collaborates with Zydus Cadila; Japanese drugmakers predict drop in profits due to patent expiries, and ERBI's CEO talks to PharmaTelevision about The Golden Triangle's partnership with Biocom
Stem Cell Research, PTV News: May 13, 2010
Mesoblast snaps up Angioblast shares in a deal over Stem Cell therapies which could generate 500 million dollars a year
Bat Research, PTV News: May 13, 2010
Tests are underway to see if proteins in vampire bat saliva can help to treat strokes
BioChicago Report, PTV News: May 13, 2010
DSM Biologics is to open the first Australia-based mammalian biopharmaceutical manufacturing facility. The MP for Queensland gives us his reaction
News Headlines, PTV News: May 13, 2010
Today's forthcoming news stories: Mesoblast snaps up Angioblast shares; DSM Biologics to open the first Australia-based mammalian biopharmaceutical manufacturing facility, and research begins into vampire bat saliva aiding treatment of strokes
Anaemia Drugs, PTV News: May 12, 2010
Merck & Co halts development of anti-anaemia treatment, giving a boost to Affymax
Implant Trials, PTV News: May 12, 2010
Living Cell Technologies CEO discusses Phase II Trials of pig cell implant treatment
COPD Therapies, PTV News: May 12, 2010
Galapagos and Roche expand their alliance to develop "smokers lung" drugs
News Headlines, PTV News: May 12, 2010
Today's forthcoming news stories: Merck & Co discontinues development of a follow-on biologic; Roche and Galapagos expand "smokers lung" drug R&D collaboration, and Living Cell Technologies discusses its latest Type 1 diabetes treatment trial
GSK Alliance, PTV News: May 11, 2010
South Korean deal continues GlaxoSmithKline's emerging markets drive
Neglected Diseases, PTV News: May 11, 2010
BIO Ventures for Global Health CEO discusses drug development incentives
OTC Kit, PTV News: May 11, 2010
Pathway Genomics genetic test goes on sale in US drugstores
News Headlines, PTV News: May 11, 2010
A look at today's forthcoming news stories: GSK has stepped up its drive into emerging markets; an over the counter genetic testing kit is launched in the US, and the head of BioVentures for Global Health tells us about R&D incentives for neglected diseases
Hepatitis C Case, PTV News: May 10, 2010
Teva Pharmaceuticals and Baxter Healthcare Services told to pay US $500M damages
Lung Drug Trial, PTV News: May 10, 2010
Novartis starts Phase 3 tests of combination COPD drug, triggering milestone payment to Vectura
Industry Outlook, PTV News: May 10, 2010
BIO President Jim Greenwood assesses the biotech industry's prospects in the wake of the global downturn
News Headlines, PTV News: May 10, 2010
A look at today's forthcoming news stories: Teva Pharmaceuticals and Baxter Healthcare Services told to pay US $500M damages; Novartis starts final stage trials of two in one lung drug, and BIO's President gives us his assessment of the state of the industry.
Endo Acquisition, PTV News: May 07, 2010
Endo Pharmaceuticals to buy HealthTronics in US $223M deal
Drug Price Cuts, PTV News: May 07, 2010
Greek government introduces new drug price regulations to cut costs
Genzyme Stock, PTV News: May 07, 2010
Genzyme Board approves US $2B stock repurchase and considers options for 3 divisions
News Headlines, PTV News: May 07, 2010
A look at today's forthcoming news stories: Genzyme's board approves US $2B stock buyback; Endo Pharmaceuticals buys HealthTronics continuing to diversify, and what impact will new Greek pricing regulations have on the pharma industry?
J&J Medicines Plant, PTV News: May 06, 2010
Production halted at McNeil Consumer Healthcare plant after medicines recall
R&D Deal, PTV News: May 06, 2010
Boehringer Ingelheim and Micromet collaborate on R&D and commercialisation of cancer therapy
Deal Restructured , PTV News: May 06, 2010
Merck & Co and Ariad restructure cancer therapy development deal
News Headlines, PTV News: May 06, 2010
A look at today's forthcoming news stories: Merck & Co restructures deal with Ariad to take control of sarcoma therapy; Boehringer Ingelheim and Micromet to collaborate on R&D for multiple myeloma, and a Johnson & Johnson subsidiary closes a production plant after recall
US Approval Denied, PTV News: May 05, 2010
FDA decides against approving Dainippon's anti-epileptic Stedesa
New Trial Data, PTV News: May 05, 2010
Pharmasset announce promising results for experimental Hepatitis C therapy
Q1 Results, PTV News: May 05, 2010
Sales up, profits down for Pfizer and Merck & Co after mega-mergers
News Headlines, PTV News: May 05, 2010
A look at today's forthcoming news stories: Sales up but profits down for Pfizer and Merck & Co after mega-mergers; disappointment for Dainippon as epilepsy drug fails to win approval, and US drug developer Pharmasset shows promising Hepatitis C drug trial data
Vimovo Approved, PTV News: May 04, 2010
Pozen and AstraZeneca's arthritis drug approved by FDA
Valeant Buys Aton, PTV News: May 04, 2010
Orphan drugmaker purchased by Valeant Pharmaceuticals in continuing buying spree
Acurox Application, PTV News: May 04, 2010
King Pharmaceuticals and Acura Pharmaceuticals to seek approval of "abuse deterrent" drug
News Headlines, PTV News: May 04, 2010
A look at today's forthcoming news stories: Valeant Pharmaceuticals continues it's buying spree; there's to be a new FDA application for King Pharmaceuticals' Acurox, and arthritis drug Vimovo’s approval sees Pozen shares soar
Angelini Labopharm, PTV News: Apr 30, 2010
Joint Venture agreed to market Oleptro in the US
Financial Results, PTV News: Apr 30, 2010
Big Pharma posted Q1 results this week, painting a positive financial picture in the wake of the downturn
Provenge Approved, PTV News: Apr 30, 2010
Dendreon vaccine becomes first cancer immunotherapy to win US approval
News Headlines, PTV News: Apr 30, 2010
A look at today's forthcoming news stories:Dendreon's Provenge, a first of a kind prostate cancer treatment, wins FDA approval; a raft of Q1 results came out this week, painting a positive financial picture for big pharma, and Italy's Gruppo Angelini and America's Labopharm agree a US $92M joint venture
Cancer Research, PTV News: Apr 29, 2010
A constituent of the spice turmeric may have a disabling effect on cancer stem cells
GSK's Avandia, PTV News: Apr 29, 2010
US authorities hear calls to halt clinical trial
Tarceva Approved, PTV News: Apr 29, 2010
Roche lung cancer drug wins further EU approval
News Headlines, PTV News: Apr 29, 2010
A look at today's forthcoming news stories: Tarceva approved as non small cell lung cancer maintenance treatment, there are calls to halt Avandia clinical trial in the US, and turmeric could the spice turn off cancer stem cells
Lucentis Study, PTV News: Apr 28, 2010
Clinical trial investigates Roche's Lucentis as treatment for diabetic sight loss
Global Profits, PTV News: Apr 28, 2010
New report says the worldwide biotech sector delivered profits for the first time last year
AZ pays US$ 520M, PTV News: Apr 28, 2010
AstraZeneca agrees settlement in Seroquel case
News Headlines, PTV News: Apr 28, 2010
A look at today's forthcoming news stories: AstraZeneca agrees US $520M settlement in illegal marketing case; biotechs worldwide turn a profit for the first time, and clinical trial finds Roche's Lucentis improves sight lost to diabetes
EU Approval, PTV News: Apr 27, 2010
AstraZeneca given green light to promote Crestor for heart disease
Ipsen & Invida, PTV News: Apr 27, 2010
South East Asian drug promotion and distribution deal
Generic Launches, PTV News: Apr 27, 2010
What will be the impact of Teva US court case?
News Headlines, PTV News: Apr 27, 2010
A look at today's forthcoming news stories: Ipsen enlists Invida for South East Asia promotion; AstraZeneca wins wider EU label approval for Crestor, and will the Teva court case affect at risk generic launches?
Sutent Trial Halts, PTV News: Apr 26, 2010
Pfizer discontinues testing of blockbuster drug in liver cancer
US $1.6B Deal, PTV News: Apr 26, 2010
Charles River Laboratories buys Shanghai's WuXi Pharma Tech
Daxas Deal, PTV News: Apr 26, 2010
Nycomed and Merck & Co agree co-promotion of lung drug
News Headlines, PTV News: Apr 26, 2010
Forthcoming stories - US clinical research firm Charles River Laboratories has agreed to buy WuXi Pharma Tech for 1 point 6 billion, Nycomed signs up Merck & Co to help market key lung drug, and Pfizer halts late stage Sutent trial for liver cancer
NHS Can Pay Docs, PTV News: Apr 23, 2010
European Court rules against pharma companies over generic incentives
Good News Bad News, PTV News: Apr 23, 2010
Positive trials of new Shin Poong malaria drug as experts warn of growing resistance to medicines
Stomach Cancer, PTV News: Apr 23, 2010
Roche’s Genentech files for new Herceptin approval
News Headlines, PTV News: Apr 23, 2010
Forthcoming stories  - European Court upholds generic incentives paid to UK doctors;  approval sought for Herceptin to treat advanced stomach cancer; and positive trials of Novartis malaria drug – but experts warn that unapproved treatments are threatening millions of lives.
Novartis Approval, PTV News: Apr 22, 2010
FDA finally gives go ahead to Zortress transplant rejection drug
Genzyme Penalty, PTV News: Apr 22, 2010
FDA indicates company will have to disgorge US$ 175M following plant contamination.
Lupus Drug Fails, PTV News: Apr 22, 2010
Human Genome Sciences’ Benlysta fails to meet secondary goals.
News Headlines, PTV News: Apr 22, 2010
Forthcoming stories - FDA gives go ahead to Novartis transplant drug six years after approval elsewhere; Benlysta blow: HGS lupus treatment fails to meet secondary goals; Genzyme told to expect disgorgement of 175 million dollars over contaminated plant.
Aisling Advice, PTV News: Apr 21, 2010
How success will breed success and give biotechs a boost

Click here to watch the Dennis Purcell interview in full
Double Digit Rises, PTV News: Apr 21, 2010
Zetia and Cymbalta lead the way as brand name pharmaceuticals record biggest price rise for a decade
Discreet Deals, PTV News: Apr 21, 2010
Why royalty rate details are hard to come by
News Headlines, PTV News: Apr 21, 2010
A look at today's forthcoming news stories: Brand name pharmaceuticals see biggest price rises in a decade; the challenge of getting royalty rates right, and reviving biotech - why success will breed success.
Market Forecast, PTV News: Apr 20, 2010
Global pharma sales “set to hit a trillion dollars” by 2014
Novartis Results, PTV News: Apr 20, 2010
Swiss pharma giant reports impressive first quarter and announces quarter billion dollar drug development deal
Deal Insight, PTV News: Apr 20, 2010
The importance of getting royalty rates right
News Headlines, PTV News: Apr 20, 2010
Forthcoming news stories – global drug sales “set to reach a trillion dollars” by 2014; Royalty Rate Report 2010 - the vital importance of getting the right deal; and Novartis reports first quarter profits up by almost a third as it signs US$ 467M cancer drug deal. "
Elan May Sell EDT, PTV News: Apr 19, 2010
Irish pharma company considers US$ 1B sale
Genetic Mutations, PTV News: Apr 19, 2010
Research indicates which cancer drugs are most (and least) effective for patients
Respiratory Generics, PTV News: Apr 19, 2010
Novartis buys Oriel for undisclosed sum
News Headlines, PTV News: Apr 19, 2010
Forthcoming stories - the tests that tell who will benefit from cancer drugs – and who won’t. Elan set to spin off its drug technologies unit; and Novartis buys Oriel to target respiratory generics.
Sanofi Trials, PTV News: Apr 16, 2010
Diabetes candidate impresses in phase III
Vital Signs, PTV News: Apr 16, 2010
Toumaz’s digital plaster to seek FDA approval
Cancer Deal, PTV News: Apr 16, 2010
Celgene and Agios in quarter billion dollar cancer metabolism pact
News Headlines, PTV News: Apr 16, 2010
A look at today's forthcoming stories: Celgene’s tumour-starving deal with Agios; stiff competition awaits for sanofi’s new diabetes drug, and digital plasters – the new technology set to revolutionise patient monitoring
Bribing Doctors, PTV News: Apr 15, 2010
Sales director of J&J subsidiary given 12 month sentence
Genzyme Hopes, PTV News: Apr 15, 2010
Troubled company celebrates positive mid-stage results for MS drug
InterMune Success, PTV News: Apr 15, 2010
Biotech shares soar on surprisingly promising Hep C drug data
News Headlines, PTV News: Apr 15, 2010
A look at today's forthcoming stories: InterMune’s shares soar on unexpectedly promising Hep C trial data; Genzyme celebrates rare good news over experimental MS drug, and the sales director of a J&J subsidiary is jailed for bribing doctors
Epilepsy Alert, PTV News: Apr 14, 2010
Research indicates heightened suicide risk of commonly prescribed anticonvulsants
BioTrinity 2010, PTV News: Apr 14, 2010
Report from UK’s premier bio-partnering and investment conference
Orexigen Blunder, PTV News: Apr 14, 2010
Biotech’s shares slide after it admits obesity drug data contained mistakes
News Headlines, PTV News: Apr 14, 2010
A look at today's forthcoming stories: Research highlights suicide risks of widely prescribed anticonvulsants; BioTrinity 2010 - the UK’s premier Biopartnering and Investment conference, and the clerical error which sent Orexigen shares plunging
Oral MS drug, PTV News: Apr 13, 2010
Novartis reports impressive performance of Gilena in phase III trials
Teva Tumour Deal, PTV News: Apr 13, 2010
Israeli generics giant in US$ 334M pact with Mersana
Roche Purchase, PTV News: Apr 13, 2010
Swiss pharma co. buys Israel’s Medingo for novel insulin patch pump
News Headlines, PTV News: Apr 13, 2010
A look at today's forthcoming stories: Teva teams up with Mersana to develop cancer drugs that stay longer in the bloodstream; Roche buys into insulin patch-pump technology, and Novartis announces positive trials for oral MS drug
Fear Factor, PTV News: Apr 12, 2010
Biogen plans PML screening test for Tysabri
Pfizer Trials, PTV News: Apr 12, 2010
Drugs giant plans 10% increase in Singapore clinical trials
Malarone Settlement, PTV News: Apr 12, 2010
GSK and Glenmark reach generic agreement
News Headlines, PTV News: Apr 12, 2010
A look at today's forthcoming stories: Biogen’s fear factor test for Tysabri; Glenmark settles with GSK over malaria patent, and Pfizer boosts clinical trials in Singapore
Pixuvri Problems, PTV News: Apr 09, 2010
Cell Therapeutics must provide new data on NHL drug
Novartis and Alcon, PTV News: Apr 09, 2010
Speculation grows that Swiss pharma company will have to raise its bid to minorities
Celgene Prospects, PTV News: Apr 09, 2010
Anti-inflammatories lead the way to diversification
News Headlines, PTV News: Apr 09, 2010
A look at today's forthcoming stories: Celgene tells Wall Street that anti-inflammatories will swell future growth; Novartis under share price pressure to up Alcon bid, and FDA demands new trials for Cell’s Pixuvri
Forest Blow, PTV News: Apr 08, 2010
FDA panel says no to Forest Laboratories' lung drug Daxas
Generics Approval, PTV News: Apr 08, 2010
Teva gets thumbs up for versions of Merck and Co's Hyzaar and Cozaar
Pre-clinical Deal, PTV News: Apr 08, 2010
Sanofi-aventis pact with CureDM to develop novel diabetes drug
News Headlines, PTV News: Apr 08, 2010
A look at today's forthcoming stories: Sanofi's US$ 335M deal for pre-clinical diabetes drug; Merck and Co loses two blockbuster patents to Teva, and FDA panel rejects Forest's COPD drug
Longevity Genes, PTV News: Apr 07, 2010
Centenarians help with research into long and healthy lives
Pfizer Optimistic, PTV News: Apr 07, 2010
Pharma giant "in a golden age" but warns of single digit growth
Multaq Blow, PTV News: Apr 07, 2010
Sanofi's heart drug dubbed "less effective and no safer" than rival
News Headlines, PTV News: Apr 07, 2010
A look at today's forthcoming stories: Pfizer trumpets new blockbusters but admits growth will be single digit; sanofi's Multaq "less effective and no safer", and how centenarians are helping in the search for longevity genes
Depressed Pilots, PTV News: Apr 06, 2010
FAA says pilots on medication are now OK to fly
Faster FDA Review, PTV News: Apr 06, 2010
Keryx and AEterna Zentaris accelerate colorectal cancer drug
Accelrys & Symyx, PTV News: Apr 06, 2010
Merger leads to US$ 335M scientific informatics software company
News Headlines, PTV News: Apr 06, 2010
A look at today's forthcoming stories: Accelrys and Symyx merge to form US$ 335M "leader in scientific informatics"; Keryx and AEterna Zentaris get fast track status for colorectal candidate, and pilots on anti-depressants are told they can fly after all
Avodart Alert, PTV News: Apr 01, 2010
Glaxo prostate drug gets combination approval amid fears it can grow tumours
Sanofi Investment, PTV News: Apr 01, 2010
French pharma giant accelerates moves towards biotechnology and vaccines
US$ 1.5B Deal, PTV News: Apr 01, 2010
GSK and Isis to develop up to 6 drugs for rare and serious diseases
News Headlines, PTV News: Apr 01, 2010
A look at today's forthcoming news stories: GSK and Isis in US$ 1.5B deal to develop rare disease drugs; sanofi changes direction towards biotechnology, and Glaxo gets approval for Avodart in combination but warns drug could grow tumours
Gene Patent Blow, PTV News: Mar 31, 2010
Biotechs reel as judge rules gene patents invalid.
Boehringer Launch, PTV News: Mar 31, 2010
€100 million Global Venture Fund
Sanofi Diversifies, PTV News: Mar 31, 2010
French pharmacompany enters medical devices with AgaMatrix
News Headlines, PTV News: Mar 31, 2010
Forthcoming news stories today -  biotechs in turmoil after judge rules cancer gene patents invalid; Boehringer's 100 million euro venture fund; and Sanofi diversifies into medical devices.
Lilly Looks East, PTV News: Mar 30, 2010
Eli Lilly plans 15 new products for Chinese market.
GenVec Fails, PTV News: Mar 30, 2010
Pancreatic cancer gene therapy drug pulled in phase III.
Free Vaccines, PTV News: Mar 30, 2010
GlaxoSmithKline deal for poor Americans.
News Headlines, PTV News: Mar 30, 2010
Forthcoming news stories - GSK to supply free vaccines to poor Americans; GenVec shares crash after failure of late stage cancer drug trials; and Eli Lilly's plans for massive expansion in China.
Merck Strategy, PTV News: Mar 29, 2010
Pamela Demain talks about the company's new out-licensing unit
Antisoma Crashes, PTV News: Mar 29, 2010
Phase III trials of lung cancer drug halted
MS Blood Test, PTV News: Mar 29, 2010
Finding out which patients are best on beta-interferons
News Headlines, PTV News: Mar 29, 2010
A look at today's forthcoming news stories: the blood test which shows which MS patients can benefit from beta interferon drugs; Antisoma shares plunge after failure of phase III cancer drug trials; and Pamela Demain on Merck and Co's licensing strategy.
HIV-Book, PTV News: Mar 26, 2010
Social networking sites used to find vaccine trial volunteers
Better Delivery, PTV News: Mar 26, 2010
BioAlliance gets approval to market Ondansetron RapidFilm
Pfizer Guilty, PTV News: Mar 26, 2010
Pharma giant committed racketeering fraud over off-label promotion of Neurontin
News Headlines, PTV News: Mar 26, 2010
A look at today's forthcoming news stories: Pfizer found guilty of racketeering over off-label promotion of Neurontin; SciClone gets European approval for anti-nausea technology, and using social media sites to recruit for HIV vaccine trials
Head-to-Head, PTV News: Mar 25, 2010
Biogen's MS drug compared with Copaxone and Rebif
Genzyme Watched, PTV News: Mar 25, 2010
FDA to take enforcement action to ensure biotech's manufacturing process up to scratch
New Approaches, PTV News: Mar 25, 2010
How big pharma, biotechs and VC are doing business post-crisis
News Headlines, PTV News: Mar 25, 2010
A look at today's forthcoming news stories: FDA set to fine Genzyme for contamination problems and oversee manufacturing operation; Biogen's Tysabri goes head to head with MS rivals, and deal-making after the economic crisis - we analyse the trends
Hepatitis C Boost, PTV News: Mar 24, 2010
Dynavax vaccine as safe as GlaxoSmithKline's Engerix-B 
Vaccine Problems, PTV News: Mar 24, 2010
Merck Serono suspends trials of Stimuvax cancer vaccine after encephalitis case
Vaccine Deal, PTV News: Mar 24, 2010
Pfizer and GSK to supply world's poorest with US $60m cut-price pneumococcal shots
News Headlines, PTV News: Mar 24, 2010
A look at today's forthcoming news stories: Pfizer and GSK in cut price vaccine deal for world's poorest; Merck Serono suspends trials of cancer vaccine after patient develops encephalitis, and Dynavax hepatitis vaccine equals GSK's rival in safety trials
James Black Dies, PTV News: Mar 23, 2010
Tributes flow in to beta-blocker pioneer
Plavix Plaudits, PTV News: Mar 23, 2010
Anti-clotting drug shown to help high risk cardiac patients
Rotarix Fears, PTV News: Mar 23, 2010
GlaxoSmithKline's rotavirus vaccine suspended by FDA amid contamination fears
News Headlines, PTV News: Mar 23, 2010
A look at today's forthcoming news stories: The FDA tells doctors to suspend vaccinations of GSK's Rotarix; Plavix study shows world's second biggest drug helps high risk cardiac patients, and beta-blocker pioneer Sir James Black has died aged 85
Lung Cancer Gene, PTV News: Mar 22, 2010
DNA research finds non-smokers' risk gene
FDA Alert, PTV News: Mar 22, 2010
Muscle injury warning issued over Zocor
Healthcare Reform, PTV News: Mar 22, 2010
Obama's US$ 940B bill set to become law
News Headlines, PTV News: Mar 22, 2010
A look at today's forthcoming news stories: Winners and losers examine Obama’s healthcare reform bill; FDA issues muscle injury alert on Zocor and generic equivalents; and finding the gene responsible for lung-cancer in non-smokers
Seroquel Victory, PTV News: Mar 19, 2010
AstraZeneca wins first court case over diabetes claims
Pay-For-Delay, PTV News: Mar 19, 2010
Patent settlement ban left out of healthcare reform legislation
Teva Buy Ratiopharm, PTV News: Mar 19, 2010
Israeli generics giant Teva buys ratiopharm to become biggest in Europe
News Headlines, PTV News: Mar 19, 2010
A look at today's forthcoming news stories: Teva pays US$ 5B for Germany's Ratiopharm - analysis with Adrian Dawkes; pay-for-delay ban is left out of US healthcare reform; and Seroquel didn't cause diabetes - AstraZeneca wins first round of court battle
Menveo Approval, PTV News: Mar 18, 2010
Novartis meningitis vaccine gets European go ahead
MS Treatment, PTV News: Mar 18, 2010
GW Pharmaceuticals expects UK and Spain approval for marijuana extract
Cholesterol Hope, PTV News: Mar 18, 2010
Genzyme and Isis announce positive phase III trials for inherited high LDL drug
News Headlines, PTV News: Mar 18, 2010
A look at today's forthcoming news stories including Genzyme and Isis announcing positive trials for rare cholesterol condition; Novartis wins European approval for meningitis vaccine and the cannabis based treatment that's en route for MS sufferers
Cancer Tests, PTV News: Mar 17, 2010
Studies aimed at finding gene signatures flawed
Missing Out, PTV News: Mar 17, 2010
Big pharma told it must try harder in China and other emerging markets
US$ 75M Raid, PTV News: Mar 17, 2010
Prescription drugs stolen from Eli Lilly warehouse
News Headlines, PTV News: Mar 17, 2010
A look at today's forthcoming news stories including big pharma's efforts to win sales in fast-emerging markets, why genetic tests on lung cancer patients are failing to deliver, and thieves get away with US$ 70M worth of Eli Lilly meds
Medtronic vs. J&J, PTV News: Mar 16, 2010
Row breaks out over whose drug-coated stent is best
Diabetes Setback, PTV News: Mar 16, 2010
FDA turns down MannKind's inhaled insulin drug
Testosterone Boost, PTV News: Mar 16, 2010
Acrux and Eli Lilly in marketing deal for underarm product
News Headlines, PTV News: Mar 16, 2010
A look at today's forthcoming news stories including the FDA's rejection of MannKind’s new insulin drug, Acrux claims its testosterone deal with Lilly is one of the biggest ever for an Aussie biotech, and Medtronic questions trials favouring J&J’s stent.
Double Trouble, PTV News: Mar 15, 2010
Roche and Pfizer cancer meds fail late stage trials
Abbott Success, PTV News: Mar 15, 2010
Abbott Laboratories' heart clip poised for blockbuster sales
News Headlines, PTV News: Mar 15, 2010
A look at today's forthcoming news stories including Abbott's latest blockbuster, and news on Roche and Pfizer's failed cancer meds
Beijing CMO, PTV News: Mar 12, 2010
Plans for Asia's biggest Contract Manufacturing Operation
Allergan boost, PTV News: Mar 12, 2010
Experts back gastric band for obese children
Verdict on Pharma, PTV News: Mar 12, 2010
Patients' groups say they don't trust big pharma
News Headlines, PTV News: Mar 12, 2010
A look at today's forthcoming news stories including Allergan's gastric band for kids gets expert backing, China plans Asia's largest CMO and patient groups say Big Pharma is "untrustworthy".
HGS seeks mAbs, PTV News: Mar 11, 2010
Human Genome Sciences in deal with BioInvent to find mAbs for its antigens
AZ in Torrent Deal, PTV News: Mar 11, 2010
AstraZeneca's plan to brand 18 generic products and market them in 9 countries
Lipids Warning, PTV News: Mar 11, 2010
Report says only half of patients are given correct LDL targets by doctors
News Headlines , PTV News: Mar 11, 2010
A look at today's forthcoming news stories including a warning that only half of high cholesterol patients get the right advice on statins, AstraZeneca's generic deal with India's Torrent and Human Genome Sciences' drug discovery pact with BioInvent
GSK Backs Cellzome, PTV News: Mar 10, 2010
GlaxoSmithKline in second drug discovery deal with Cellzome
Novartis Cancer Bet, PTV News: Mar 10, 2010
Pharma giant spends US$ 10M on option to buy rights for Transgene's cancer candidate
Abbott Buys Facet, PTV News: Mar 10, 2010
Facet shareholders celebrate as Abbott trumps Biogen offer by 54%
News Headlines , PTV News: Mar 10, 2010
A look at today's forthcoming news stories including Facet celebrations as Abbott bid beats Biogen by 54%, Novartis' US$ 10M gamble on Transgene's cancer drug and GSK's second drug development deal with Cellzome
Cancer Pain Success, PTV News: Mar 09, 2010
Insys reports positive phase III trials for sublingual Fentanyl spray
Genmab Share Plunge, PTV News: Mar 09, 2010
Phase III trials of cancer drug fail to meet primary end point of improved survival
Animal Health JV, PTV News: Mar 09, 2010
Merck & Co. and sanofi-aventis target US$ 19B market
News Headlines , PTV News: Mar 09, 2010
A look at today's forthcoming news stories including a Merck & Co./sanofi-aventis pact, the Genmab share dive and positive trial results for cancer spray
ratiopharm Wooed, PTV News: Mar 08, 2010
Pfizer chiefs tell German generics company why they should win sell-off battle
AstraZeneca Cancer Drug Beaten, PTV News: Mar 08, 2010
AstraZeneca's Recentin can't better Roche's Avastin in colon cancer trials
Roche Drug Pulled, PTV News: Mar 08, 2010
Rheumatoid arthritis treatment causes deaths
News Headlines , PTV News: Mar 08, 2010
A look at today's forthcoming news stories including Roche's drug suspension, AstraZeneca coming in second, and Pfizer's fight for Ratiopharm
Winners & Losers, PTV News: Mar 05, 2010
Analysing the effect of the recession on deals and assessing the impact of health care cost concerns on pharma.
Cancer Trial Results, PTV News: Mar 05, 2010
Dendreon's Provenge and sanofi-aventis' Cabazitaxel show positive data
Vaxart Funding, PTV News: Mar 05, 2010
US Biotech secures US$ 12.5M funding for oral vaccine portfolio
News Headlines , PTV News: Mar 05, 2010
A look at today's forthcoming news stories including secured funding for Vaxart, Sanofi-Aventis' positive cancer trial data, and Deals in a Downturn part 3
Risk Aversion, PTV News: Mar 04, 2010
Analysing the effects of risk aversion on pharma deals in a global recession
Dimebon Study, PTV News: Mar 04, 2010
Medivation and Pfizer Phase III trial fails to meet endpoints
Development Deal, PTV News: Mar 04, 2010
Bristol-Myers Squibb and Allergan in US$ 400M pain drug pact
News Headlines , PTV News: Mar 04, 2010
A look at today's forthcoming news stories including the US$ 400M Bristol-Myers Squibb/Allergan deal, disappointment for Medivation's Alzheimier's drug, and Deals in a Downturn part 3
Components & Trends, PTV News: Mar 03, 2010
Analysing deal payments in a time of financial turmoil
AstraZeneca Jobs Go, PTV News: Mar 03, 2010
1800 jobs cut and research centres close as AstraZeneca restructures R&D
Archimedes US$100M , PTV News: Mar 03, 2010
Biggest funding round by a Euro biopharma in 15 years
News Headlines , PTV News: Mar 03, 2010
A look at today's forthcoming news stories including Archimedes' US$ 100M fundraiser, AstraZeneca's R&D shake-up, and Deals in a Downturn part 3
Volume & Value, PTV News: Mar 02, 2010
PharmaVentures analysis of the impact of the financial crisis on pharma-deals
AstraZeneca Buy Back , PTV News: Mar 02, 2010
British company exercises option to buy out Merck & Co's interest in some of its products.
Astellas OSI Bid, PTV News: Mar 02, 2010
Japanese drugmaker to take US$ 3.5B offer to shareholders
News Headlines , PTV News: Mar 02, 2010
A look at today's forthcoming news stories including Astellas' hostile takeover bid, AstraZeneca purchasing Merck & Co's interests, and Deals in a Downturn part 2
Shire Shares Rise , PTV News: Mar 01, 2010
Stocks hit nine year high after US FDA approve Gaucher drug
Merck KGaA Deal Agreed, PTV News: Mar 01, 2010
German pharma giant buys US lab supplies maker
Financial Crisis, PTV News: Mar 01, 2010
The impact on the types of pharma and biotech deals
News Headlines , PTV News: Mar 01, 2010
Sold: Merck & Co. agrees to buy Millipore for US$ 7.2 billion

Vpriv Approved: Shire granted US marketing approval for Gaucher medication

Deals in a Downturn: Assessing the effect of the global financial crisis biotech and pharma
Patent Cases, PTV News: Feb 26, 2010
Pfizer, Procter & Gamble, Kimberly-Clark facing potential suits in US courts following appeal ruling
IPO Postponed, PTV News: Feb 26, 2010
Further evidence of chilly health care investment scene
Boost For Roche, PTV News: Feb 26, 2010
Positive results for Avastin from advanced ovarian cancer trial
News Headlines , PTV News: Feb 26, 2010
Avastin Advance: Positive cancer trial results boost Roche blockbusters’ prospects

Anthera Delays: There'll be no IPO in a chilly investment environment

Claims Rush: Pharma facing US court claims over wrongly marked packaging
Pfizer Wins Approval, PTV News: Feb 25, 2010
Prevnar 13 childhood pneumococcal vaccine approved in US
Generic Drugs, PTV News: Feb 25, 2010
US FTC case dismissed, but what does it mean for big Pharma?
Cephalon Purchase , PTV News: Feb 25, 2010
New data drives Cephalon to exercise option to buy Ception
News Headlines, PTV News: Feb 25, 2010
Megablockbuster: Pfizer's Prevnar 13 approved

Pay for Delay: US generics lawsuit dismissed

Asthma asset: Cephalon pays US$ 250M for Ception
Asian cancer pact, PTV News: Feb 24, 2010
Lilly, Merck & Co. and Pfizer team up to create research database.
Global partnership, PTV News: Feb 24, 2010
Astellas and Basilea team up to develop and market antifungal
News Headlines , PTV News: Feb 24, 2010
Joining forces: Pharmagiants team up to fight cancer in Asia

Fighting fungus: Astellas in US$ 500M deal with Basilea

Asthma asset: Cephalon pays US$ 250M for Ception
GSK's £500M investment, PTV News: Feb 23, 2010
UK tax cut on patents sees GlaxoSmithKline create a thousand jobs
AstraZeneca pays outstanding tax , PTV News: Feb 23, 2010
AstraZeneca settles £505M bill and raises EPS forecast
Anthera floats, Fluidigm hesitates , PTV News: Feb 23, 2010
IPO environment still shaky as healthcare flotations falter
News Headlines , PTV News: Feb 23, 2010
Patent box: UK tax break sees GlaxoSmithKline create 1000 jobs

Mixed messages: Anthera plans US$ 69M IPO while Fluidigm thinks twice

Settled: AstraZeneca pays taxman US$ 780M and raises forecast for 2010 earnings
GSK and FDA accused, PTV News: Feb 22, 2010
US Senate probes decision to allow trials of "dangerous" Avandia
Meningitis and MS, PTV News: Feb 22, 2010
Swiss pharma-giant celebrates double triumph
Undercutting Genzyme, PTV News: Feb 22, 2010
Shire plans 15% discount on new Gaucher drug
News Headlines, PTV News: Feb 22, 2010
Price war: Shire to undercut Genzyme over new Gaucher drug

Too cosy: Senators attack the FDA and GlaxoSmithKline over Avandia

Super Novartis: Approval for one drug, fast-track for another
Tasigna fast-tracked , PTV News: Feb 19, 2010
Novartis toasts potential successor for leukemia blockbuster
New approval for Rituxan, PTV News: Feb 19, 2010
FDA give green light to Roche blockbuster for CLL
Safety fears, PTV News: Feb 19, 2010
FDA wants clampdown on prolonged use of leading asthma drugs
News Headlines, PTV News: Feb 19, 2010
Asthma alert: FDA bans prolonged use of blockbuster treatments

Wonder drug – another use approved for Roche’s Rituxan

Son of Glivec – Novartis’ successor drug gets priority review
Prostate prize , PTV News: Feb 18, 2010
J&J's Cougar billion dollar gamble set to pay off after positive cancer trials
Briefing , PTV News: Feb 18, 2010
FDA rejects GSKL's Horizant

FDA approved Sorin's new heart-lung machine

J&J cuts bonuses
FDA probes device approvals, PTV News: Feb 18, 2010
Plans to curb fast-track thumbs up for medical devices
REMS program, PTV News: Feb 18, 2010
FDA approves Amgen/J&J risk control and mitigation
News Headlines, PTV News: Feb 18, 2010
Risks controlled: Amgen and J&J satisfy the FDA’s stricter safety measures

New hope: Impressive results for Johnson and Johnson’s prostate cancer candidate

Raising the bar: Medical device manufacturers face tougher scrutiny
Statins side-effects, PTV News: Feb 17, 2010
Cholesterol busters can cause diabetes
Merck & Co.'s mixed message, PTV News: Feb 17, 2010
Merck & Co announces soaring sales but slashes jobs
Lilly's Effient flop, PTV News: Feb 17, 2010
Eli Lilly's blood thinning "blockbuster" fails to deliver
News Headlines, PTV News: Feb 17, 2010
Flopped: Eli Lilly's Effient fails to gain a toe-hold

Profits soar, jobs slashed: Merck & Co.'s mixed bag

Statins side effect: Cholesterol drugs can up diabetes risk
Briefing , PTV News: Feb 16, 2010
Alzheimer's gene boosts young minds

Botox "reduces migraines"

Cutting the stink of diabetes drug
Vote of Confidence, PTV News: Feb 16, 2010
AstraZeneca in billion plus deal for failed RA drug
Fake Drugs, PTV News: Feb 16, 2010
Illicit trade: Europe's counterfeit drugs market "worth 10.5 billion Euros"
Teva Triumph, PTV News: Feb 16, 2010
The world’s biggest generics company reports Q4 profits up 28%
News Headlines, PTV News: Feb 16, 2010
Vote of confidence: AstraZeneca in billion plus deal for failed RA drug

Teva triumph: The world’s biggest generics company reports profits up 28%

Faking it: Europe's counterfeit drugs market "worth US$ 10.5B"

[Feb 16, 10:30 GMT]
Pig Cell Potential, PTV News: Feb 15, 2010
A revolutionary treatment for type 1 diabetes. We interview Paul Tan, the CEO of Living Cell Technologies.

[Feb 15, 16:10 GMT]
Qualified Approval, PTV News: Feb 15, 2010
Novo Nordisk gets Victoza go ahead in the UK, but only in combination.

[Feb 15, 15:00 GMT]
Speed Reader, PTV News: Feb 15, 2010
Genome sequencing as common as a routine check-up. PharmaVentures' Adrian Dawkes comments on the implications for drug development.

[Feb 15, 13:20 GMT]
News Headlines, PTV News: Feb 15, 2010
Qualified approval: Novo Nordisk gets limited OK for Victoza

Speed reader: Genome sequencing "as common as a routine check-up"

Pig cell-potential: A revolutionary treatment for type 1 diabetes

[RELEASED 11:20 GMT]
Blockbuster Potential?, PTV News: Feb 12, 2010
Roche’s diabetes drug wows in late trials.
[RELEASED 15:00 pm GMT]
Gaucher rivals, PTV News: Feb 12, 2010
Genzyme set to lose blockbuster monopoly. Interview with Andy Smith, Axa Framlington Biotech Fund.
[RELEASED 15:00 pm GMT]
Generics? No Thanks!, PTV News: Feb 12, 2010
Generics? No Thanks!

AstraZeneca chief bucks copy-cat trend. Interview with PharmaVentures' Jansen Jacob.
[RELEASED 13:00 pm GMT]
News Headlines, PTV News: Feb 12, 2010
Gaucher rivals: Genzyme set to lose blockbuster monopoly

Generics- no thanks: AstraZeneca chief bucks copy-cat trendGaucher rivals:

Genzyme set to lose blockbuster monopoly
[RELEASED 10:30 am GMT]
Safety improvements, PTV News: Feb 11, 2010
Safety improvements:

Merck &Co in new shareholder settlement over Vioxx
[RELEASED 15:45pm GMT]
Deep breaths, PTV News: Feb 11, 2010
Deep breaths:

Alexza and Biovail sign US$ 130M deal to develop inhalable anti-psychotic
[RELEASED 14:30]
Four Legged Friends, PTV News: Feb 11, 2010
Four-legged friends:

Sanofi moves towards 20 billion dollar animal health tie-up with Merck and Co. Interview with PharmaVentures Steven Renwick.
[RELEASED 13:30]
News Headlines, PTV News: Feb 11, 2010
Animal health: Sanofi-Aventis plans US$ 20B tie-up with Merck

Alexza and BioVail in inhalable antipsychotic deal

Vioxx closure: final settlement for the last lawsuits [RELEASED 11:00]
Vindicated, PTV News: Feb 10, 2010
Vindicated:
ReNeuron wins approval for stem cell trials on stroke patients. Chief Exec interview.
Briefing, PTV News: Feb 10, 2010
Briefing:
Swine flu helps Sanofi
Tysabri boosts BioGen
Elan's expectations
Diversification, PTV News: Feb 10, 2010
Diversification:
Camera-maker Fujifilm’s foray into generic drugs
Invalid, PTV News: Feb 10, 2010
Invalid:
UK court overturns gene sequence patent. We examine the implications withe PharmaVentures' Joe Walker
News Headlines, PTV News: Feb 10, 2010
News Headlines:

Invalid: gene sequence patent overturned by UK court

Diversification: camera-maker Fujifilm’s foray into generic drugs

Vindicated: ReNeuron can treat stroke patients with stem cells

[RELEASED 10:30 am GMT]
eCard Drugs, PTV News: Feb 09, 2010
eCard Drugs:

Pfizer's electronic payment system for emerging markets. [RELEASED 15:10 pm GMT]
Briefing, PTV News: Feb 09, 2010
Briefing:


Amgen bone drug beats Novartis

FDA decision boosts Anthera IPO

Crucial Cell meeting postponed [RELEASED 14:45]
Healthier Hearts, PTV News: Feb 09, 2010
Healthier Hearts:
FDA approves wider use for AZ's Crestor. Analyst interview.
Rejected, PTV News: Feb 09, 2010
Rejected:
UK' s health cost regulator turns down Novartis's Afinitor [released 12:30 pm GMT
News Headlines, PTV News: Feb 09, 2010
News Headlines
[Released 10:40 GMT]

FDA approves wider use for AZ's Crestor

UK' s health cost regulator rejects Novartis's Afinitor

Pfizer's eCard for emerging markets
Briefing, PTV News: Feb 08, 2010
News in Brief: BioMarin buys LEAD Therapeutics for US$ 97M, Tacere in Hep C deal with Pfizer, Korea's US$ 1.7B drug discovery fund
Warned, PTV News: Feb 08, 2010
Warned: Ranbaxy Labs told to clean up act at manufacturing plants
Double Vision, PTV News: Feb 08, 2010
Double vision: why two drugs treating the same disease successfully are priced so differently
Stemming Cancer, PTV News: Feb 08, 2010
Dr Trevor Yeung from Oxford University's Weatherall Institute of Molecular Medicine explains how they've speeded up studies of cancer stem cells, making them easier to grow in the lab.
News Headlines, PTV News: Feb 08, 2010
PTV News: Feb 5th, 2010
Top stories on February 5th, 2010:

Cutting costs: Glaxo snips away at drug discovery

Misleading: Big Pharma warned again about prescription drug promotions

Taminco pulls IPO citing unfavourable market conditions

News in Brief

The "artificial pancreas" bringing hope to diabetics
PTV News: Feb 4th, 2010
Top stories on February 4th, 2010:

Malaria breakthrough: The vaccine protecting children from killer disease

Early investment – Glaxo bets on Apeiron’s phase I lung drug

Ratiopharm sale "a two horse race"

News in brief: Neurosearch's successful trials, BMS freezes salaries, AstraZeneca faces 26,000 Seroquel suits

Market growth: Could booming babies boost Viagra profits?
PTV News: Feb 3rd, 2010
Top stories on February 3rd, 2010:

Roche profits plummet after Genentech integration costs

Spectrum analysis: TopoTarget’s belinostat viewed as good bet

Amgen battles Teva over generic Neupogen

Company News in Brief: Ironwood IPO, Galapagos buys Argenta unit, Abbott's deal with Pierre Fabre

Hands up: FDA approval for Dupuytren’s drug
PTV News: Feb 2nd, 2010
Top stories on February 2nd, 2010:

German generics – Cephalon pays half a billion for Mepha

Big pharma told to in-license experimental drugs

Stent settlement – Boston Scientific pays Johnson & Johnson in patent row

Research news in brief

The ghost molecule that makes RA cells commit suicide
PTV News: Feb 1st, 2010
Top stories on February 1st, 2010:

Targeting jobs: GSK’s plans to slash workforce

Floating: Ironwood hopes to raise a quarter billion

Flexion flexes muscles with four big pharmas

Daiichi seeks Japanese approval for Laninamivir

The ins and outs of tax-breaks for R&D

Man boob bonanza: The surge in male breast reductions
PTV News: Jan 29th, 2010
Top stories on January 29th, 2010:

Mixed messages: Big pharma’s differing predictions

Icahn's stalking Biogen again

News in brief

Stalling schizophrenia: Could early intervention stop disease development?

Super survivors: The drugs that could keep soldiers alive
PTV News: Jan 28th, 2010
Top stories on January 28th, 2010:

Dumped: Pfizer drops 100 experimental drugs

Drug abuse: Jackson’s death focuses new FDA guidelines

Amgen and GSK in Enbrel promotion pact

Action Shares

Appetite regulator Leptin to enter trials

Better than Viagra: Why a president prefers pork

PTV News: Jan 27th, 2010
Top stories on January 27th, 2010:

Unenforceable: Court rules against Merck & Co. over Temodar patent

Sniffing cancer: How odour sensing locates lung tumours

900 jobs in Texas personalised healthcare JV

Action Shares

Novartis warns governments over H1NI contracts

True grit: A new use for unused flu drugs
PTV News: Jan 26th, 2010
Top stories on January 26h, 2010:

Quitting while he’s ahead: Novartis boss steps down as profits go up

Novo Nordisk eyes diabetes blockbuster

Banned: AIDS Foundation tells Merck & Co. reps they’re not welcome

Action Shares

AstraZeneca denies it "pressurised" manager over Seroquel weight risks

The eyes have it: How ancient Egyptians’ make-up fought infections
PTV News: Jan 25th, 2010
Top stories on January 25th, 2010:

Walking with Elan: MS drug gets FDA approval

Hiring hundreds: Genzyme forecasts better days ahead

Huge growth predicted in obesity drug market

Action Shares

Novartis fund to develop drugs for neglected diseases

Milking it: how bunnies are helping stroke victims
PTV News: Jan 22nd, 2010
Top stories on January 22nd, 2010:

Pulled: Abbott’s Meridia deemed too dangerous

Difficile defeated? Merck’s dramatic trial results

Glaxo warning about South African power hikes

Action Shares

"Silent pandemic" - the diseases threatening developing health systems

Sitting uncomfortably - the health risks of desk-life
PTV News: Jan 21st, 2010
Top stories on January 21st, 2010:

Blood ties: Ipsen and Inspiration unite to fight haemophilia

Roche and Koreans in Alzheimer's alliance

'Grossly inadequate':Alcon directors’ verdict on Novartis bid

Action Shares

Galloping Galapagos: "number one biotech in the world". Recorded at BioBusiness 2010, London

Extraordinary Measures: the Genzyme movie starring Harrison Ford
PTV News: Jan 20th, 2010
Top stories on January 20th, 2010:

Obama healthcare reforms "on life support" after Republican victory

Turning Japanese: Novartis gets approval for three drugs

GenVec in hearing loss deal with Novartis

Action Shares

GSK opts for slim profits from malaria vaccine

Wizard wasps: the tiny insects aiding genetic research
PTV News: Jan 19, 2010
Top stories on January 19th, 2010:

Enemy Alli – FDA warns of counterfeit weight loss drug

Getting personal – AstraZeneca’s diagnostics deal with Dako

Teva and Pfizer "last contenders" in battle to buy Ratiopharm

Personalised medicine - Argos style

Fair competition: Bayer denies Levitra price fixing
PTV News: Jan 18, 2010
Top stories on January 18th, 2010:

Under fire: J&J criticised over kickbacks and drug recall delays

Eastern treasure: Glaxo forecasts 10% growth in Asia-Pacific

Global healthcare fraud "costs US$ 260B"

Action Shares

Fully integrated healthcare - Ernst and Young's vision for 2010

Petri dish pork: Could meat be grown in the lab?
PTV News: Jan 15, 2010
Top stories on January 15th, 2010 (100th programme):

Not guilty: Top WHO official denies swine flu conspiracy

Novartis embraces smart pill technology

Merck & Co seeks new approval for Gardasil

Action Shares

Breast cancer breakthrough: New ways of blocking oestrogen

And poo bear: The droppings giving clues about MRSA
PTV News: Jan 14, 2010
Top stories on January 14th, 2010:

Alzheimer’s bonanza: Blood pressure drugs "stop disease progression"

Rare opportunity: Actelion gets new approval for Zavesca

Diabetes epidemic: The true cost revealed

Action Shares

2010 according to Novartis

Why oh why? How the male chromosome is evolving fastest
PTV News: Jan 13, 2010
Top stories on January 13th, 2010:

Takeover rebels: Novartis buyout of Alcon under threat

Paying off: GSK’s three year old Crohn’s deal

Tysabri fears overcome with blockbuster status

Action Shares

"Misleading" - big pharma rapped for exaggeration

Fat chance: Why weight on your hips, bum and thighs is healthy
PTV News: Jan 12, 2010
Top stories on January 12th, 2010:

Scare-mongering: European health chiefs accuse big pharma over swine flu

Japan set to welcome Indian generics

Inhaler delayed – MannKind hit by last minute FDA decision

Action Shares

Seeking synergy - Pfizer and Merck & Co announce latest job cull

Vanquishing Viagra: Vivus drug "works twice as fast"
PTV News: Jan 11, 2010
Top stories on January 11th, 2010:

Actemra approved: Roche RA gets FDA green light

CKD deal: Reata Pharmaceuticals inks licensing pact with Kyowa Hakko Kirin

Teva soars to 15-year high on revenue forecast of US $31Bn in 2015

Action Shares

Alien invaders: Study reveals 8% of 'human' DNA comes from viruses

Gene genius: Neuroscientists combine herpes and 'Sleeping Beauty' to improve gene therapy
PTV News: Jan 8, 2010
Top stories on January 8th, 2010:

Huge potential: Vivus obesity drug cuts sleep apnea too

Lundbeck investigated by EU over generic claims

Second stab: Debiopharm to develop Pfizer failure

Cyclacel's changing fortunes

Action Shares

Risk averse: Why Australian investors are still shy of biotech

Glaxowood: Why the drugs giant is financing a film about over-eating
PTV News: Jan 7, 2010
Top stories on January 7th, 2010:

HIV hopes – Gilead’s quad programme in trials triumph

Schizophrenia success: Dainippon bids for early approval

Pfizer's off patent deal with India's Strides Arcolab

Action Shares

AstraZeneca and Teva shake hands over Nexium

Cell phone surprise: Could mobile chit-chat reverse Alzheimer’s?
PTV News: Jan 6, 2010
Top stories on January 6th, 2010:

In a special programme, PharmaVentures' Nigel Borshell talks about the trends in Mergers and Acquisitions as the industry enters a new decade. The programme covers:

Why biotechs are being bought earlier in their development stage

Why M&A deals with earnouts are on the increase

And take-over premiums: are public companies getting cheaper to buy?
PTV News: Jan 5, 2010
Top stories on January 5th, 2010:

Targeting cancer: RNAi minnow in billion plus pact

Wrinkle power: Merz’s move into aesthetic medicine

Genzyme's "fill and finish" deal with Hospira

Action Shares

Venturing forth: Merck Serono's 40M Euro investment fund

The C factor: How a humble vitamin fights accelerated ageing
PTV News: Jan 4, 2010
Top stories on January 4th, 2010:

Eyeing success: Novartis pays US$ 40Bn dollars for Alcon

AstraZeneca and Forest in half billion dollar deal to buy Novexcel

Pfizer's lung cancer drug fails phase III trials

Action Shares

Sweet charity: Cancer Research UK in drug development deal with Merck

Man’s best friend: How dogs could sniff out a cure for OCD
The Future
The Future

Paul Larsmon reviews a series of interviews with some of Pharma and Biotech’s biggest players, including Doug Giordano from Pfizer, Dan Zabrowski from Roche and Jean-Claude Muller from Sanofi-Aventis. In this programme we look forward to 2010 and beyond within the industry and see what predictions will be made for its future.
Round Table
Round Table

Paul Larsmon introduces an interview chaired by Pharmaventures Fintan Walton with Andy Smith from Axa Framlington, Sam Fazeli from Piper Jaffray and Stephen Parker from Celtic Pharma. 2009, the industry and the future for the sector are discussed in this in-depth ‘round table’ interview.
Action Shares
Action Shares

Paul Larsmon introduces a review of the biggest movements on the 2009 stock market. Presented by Nemi Douglas from the PharmaTelevision News team.
New Ways
New Ways

Paul Larsmon presents a series of interviews with some of Pharma and Biotech’s biggest hitters, including Mervyn Turner from Merck & Co, Clive Dix of BIA and Vaughn Kalian from MPM Capital. In this programme we reflect on the industry and see how the sector is reacting to the current climate with new ways of conducting business.
And Finally...
And Finally...

Paul Larsmon presents a collection of this year's favourite “and finally” stories.
PTV News: Dec 23, 2009
Top stories on December 23rd, 2009:

Novartis buys Cothera and experimental heart drug Relaxin

Biovitrum sells obesity program to AstraZeneca

Potency problems force AstraZeneca to recall 4.7M Flumist doses

Action Shares

Arena files for FDA approval of obesity drug Lorcaserin

Scientists discover cholesterol lowering properties of Myrrh
PTV News: Dec 22, 2009
Top stories on December 22nd, 2009:

Sanofi snaps up Chattem in US$ 1.9Bn deal

Eli Lilly takes US$ 90M gamble on Incyte arthritis treatment

Seattle Genetics scoops US$ 402M Glaxo ADC deal

Action Shares

EMEA orphan status for Cell Therapeutics Pixantrone

Superbug superfruit: Is pomegranate the new weapon against MRSA?
PTV News: Dec 21, 2009
Top stories on December 21st, 2009:

Amgen’s Denosumab poised for EU approval

Celgene's Revlimid meets Multiple Myeloma trial goal

Astellas forges US$ 390M oncology pact with Ambit Biosciences

Action Shares

Eisai inks US$ 255M deal to buy AkaRx

Toxic cocktail: Why bourbon contains a hangover punch
PTV News: Dec 18, 2009
Top stories on December 18th, 2009:

Return to sender: unused swine flu vaccine going back to manufacturers

Merck ventures deeper into Biotech

Aveo floats to support kidney drug trials

Action Shares

Moving on: Biogen and Facet call it quits

And Vegas Mixx: the viagra-valium combo that’s upset the authorities
PTV News: Dec 17, 2009
Top stories on December 17th, 2009:

Mapping cancer: The genetic mutations that turn healthy cells into tumours

OSI "could lose US $400M sales" after Tarceva's turned down

Celgene's psoriasis success

Action Shares

The poor man of Europe – why the UK spends least on medicines

Bad Santa – promoting obesity and drink-driving
PTV News: Dec 16, 2009
Top stories on December 16th, 2009:

Holy grail or poisoned chalice: The latest Alzheimer’s setback

Flu vaccine recall: Sanofi pulls 800-thousand toddler doses

Amgen and Array in diabetes deal

Action Shares

Takeda's salesforce coup in China

Bubbly bonus: Why champagne is good for the heart
PTV News: Dec 15, 2009
Top stories on December 15th, 2009:

Seattle's Takeda deal counters Roche pain

Injectable Zyprexa gives Lilly new patent protection

Australia's ChemGenex in licensing deal with Hospira

Action Shares

"Disheartening" data knocks hopes of AIDS infection gel

Allergan goes on the offensive over Bo-Tax
PTV News: Dec 14, 2009
Top stories on December 14th, 2009:

Astra loses first battle in Crestor patent war

Elan's NanoCrystal gets approval in Japan

Cubist expands anti-superbug portfolio 

Action Shares

Roche trumpets"unparalleled drug development"

Cold facts: How a call from the weatherman could save lives
PTV News: Dec 11, 2009
Top stories on December 11th, 2009:

Green light for Gilead’s cystic fibrosis inhaler

Blockbuster hopes for rheumatoid arthritis drug

GSK: "We'll win emerging markets race"

End of the road – Facet says no to Biogen’s "final" offer

Action Shares

Sickle Cell anaemia breakthrough

Mud glorious mud - why dirty babies make healthier adults
PTV News: Dec 10, 2009
Top stories on December 10th, 2009:

Raided: European watchdog descends on big pharma

Glaxo’s hopes for clogged artery blockbuster

Regeneron bucks dismal pharma job scene

Sanofi's antibody deal with Alopexx

Action Shares

Investment director says IPOs "set to return"

Christmas cheers: Why beer cuts the risk of prostate cancer
PTV News: Dec 9, 2009
Top stories on December 9th, 2009:

Pfizer's plans to copy rivals' biologics

Son of Gleevec: Novartis says Tasigna is a better drug

Roche dumps Actelion to concentrate on Genentech

Action Shares

The computer programme matching molecules to target flu

The pharma boss who says banning Barron is "dopey"
PTV News: Dec 8, 2009
Top stories on December 8th, 2009:

No more needles: Clinical trials start on diabetes pill

Celgene expands cancer drug portfolio

Information overload: "Patients ignore drug warnings"

Somaxon's Silenor turned down again: Shares slump

Action Shares

The genetic link between adult diabetes and childhood obesity

The gene research facility that "looks like a chromosome"
PTV News: Dec 7, 2009
Top stories on December 7th, 2009:

Treanda triumph: Data gives Cephalon blockbuster hopes

Novartis celebrates Incyte's myelofibrosis trials

TB challenge: Appeal for better tests and new drugs

Depression-beater: AZ's Seroquel gets new add-on status

Action shares

South Africa's biotech revolution
- watch the full-length Antonio Llobell interview here

The kangaroo cure for skin cancer
PTV News: Dec 4, 2009
Top stories on December 4th, 2009:

"Take it or leave it" - Biogen's final offer to Facet

Why Novartis should buy out Alcon’s minority shareholders

Vertex sells shares to fund drug development

Action Shares

Sanofi enters Alzheimer's market

Eli Lilly rules out mega-mergers

The rejection gene which means love really can hurt
PTV News: Dec 3, 2009
Top stories on December 3rd, 2009:

AZ in billion dollar deal for Targacept's antidepressant

Roche's diabetes drug "better than Merck's Januvia"

Dyax shares skyrocket on FDA approval of Kalbitor

Action Shares

Stemcell boost from US government: "markets over-react"

Takeda goes shopping in India

Pfizer boss tells corporate America to clean up its act
PTV News: Dec 2, 2009
Top stories on December 2nd, 2009:

Pfizer's direction-changing Protalix deal

Better-healing bone breakthrough

Trellis licenses MedImmune for antibodies

Action Shares

Big pharma "faces bigger tax bills"

Switzerland fines big pharma for pricing dysfunction

Curing alcohol abuse - with cannabis
PTV News: Dec 1, 2009
Top stories on December 1st, 2009:

Sales of Celgene's Revlimid "set to triple" on new trial data

Pfizer plans generic assault on Japan

Mystery over FDA setback for Merck's cladribine

Action Shares

Abbott and Teva strike patent deal over TriCor

Hopes of mental illness breakthrough as "madness gene" identified

Harvesting milk teeth for stem cells - at a price
PTV News: Nov 30, 2009
Top stories on November 30th, 2009:

Bayer's "reliable Alzheimer's test" starts phase III trials

GSK to slash developing world drug bill

Takeda goes hunting in South America

Sanofi's AT "blockbuster" gets European approval

Action Shares

Stiff challenge as UK takes on US life science clusters

Appendix app: How smart phones could save lives
PTV News: Nov 27, 2009
Top stories on November 27th, 2009:

Too little too late: Traditional vaccine methods trail pandemics

Osteoporosis hopes as late stage trials show positive results

Roche boss says company will outpace the market

Diabetes set to double over 25 years

Action Shares

More big-pharma collaborations forecast by Pfizer head

"Himalayan Viagra" seized en route to China
PTV News: Nov 26, 2009
Top stories on November 26th, 2009:

Unfortunately there is no PharmaTelevision News today as we are relocating our studio. PharmaTelevision News returns tomorrow to bring you the all the latest news on the business of healthcare.
PTV News: Nov 25, 2009
Top stories on November 25th, 2009:

Incyte's "billion dollar deal" with Novartis

China's US$ 50M Nasdaq IPO

Pfizer looks east for R&D expansion

Niaspan profits as trial data hits Merck's Zetia

Action Shares

Widely prescribed drugs "increase falling risk" for elderly

The shock therapy which could challenge Viagra
PTV News: Nov 24, 2009
Top stories on November 24th, 2009:

Cephalon's Cinquil set-back

Biogen CEO attacked over share sales and pay

Merck Serono plans global R&D centre in China

Norway's Clavis in US$ 380M development deal

Action Shares

Teva "jumps gun" with Novartis generic

"Take your tablets!" -  the nagging pill bottles
PTV News: Nov 23, 2009
Top stories on November 23th, 2009:

Roche's Actemra: Positive trials for children's pain

Traumatic brain injury: Car crash victims recruited

FDA set-back for caterpillar flu vaccine

Green shoot hopes as two companies launch IPOs

Action Shares

Australian biotech leads asia-pacific recovery

Rat cunning: The altered gene that boosts intelligence
PTV News: Nov 20, 2009
Top stories on November 20th, 2009:

Illegal online drug sales: Arrests and seizures

Pfizer plans generic assault on Japan

Curing blindness, creating skin: The march of stem cell technology

Action Shares

Revived blockbuster hopes for Xsarelto

Australian biotech chases cancer cure-all

European pharma "buys murder victims' fat"
PTV News: Nov 19, 2009
Top stories on November 19th, 2009:

Why bird flu didn't develop into a pandemic

Plavix efficacy "halved" by PPIs

Jinxed Genzyme abandons experimental CKD drug

Action Shares

Qiagen goes shopping with US$ 1B to spend

Cabbage molecule could cut acetaminophen toxicity

The gene that protects cannibals from brain disease
PTV News: Nov 18, 2009
Top stories on November 18th, 2009:

Safety concerns and delays undermine positive Isis trials

NICE rejects BMS and Novartis leukaemia drug

NicOx raises US$ 150M to push osteoarthritis drug

Action Shares

Jobs: BMS hiring - UCB firing

Patients' own stem cells help ease angina pain

The "cancer ingredient" in hundreds of household products
PTV News: Nov 17, 2009
Top stories on November 17th, 2009:

Glaxo's US$ 500M anti-smoking vaccine deal

FDA delays approval of Genzyme's Pompe drug

Share crash: Poniard pays the price of Phase III failure

Action Shares

Frozen out: Iceland's DeCODE files for Chapter 11

Greener and cheaper: GSK's plans to cut waste in drug production

Light and algae: the developing science of optogenetics
PTV News: Nov 16, 2009
Top stories on November 16th, 2009:

Merck's Zetia "less effective, more dangerous" than rival

BMS spins off Mead Johnson

Boehringer set to unveil female sex dysfunction drug

Action Shares

Talecris bucks trend and starts hiring

Sibling genes work together to kill cancer

Dark chocolate: the latest cure-all claims
PTV News: Nov 13, 2009
Top stories on November 13th, 2009:

Pharma and finance go head to head in Ratiopharm sale

How climate change is boosting skin cancer treatments

Astex's "half billion dollar" deal with GSK

Action Shares

Pfizer fights back against Neurontin critics

Online drug promotions: FDA set to act

DNA dating - finding love genetically
PTV News: Nov 12, 2009
Top stories on November 12th, 2009:

Blockbuster anaemia drugs in new safety fears

Novartis chief attacks Indian IP protection

Healthcare job cuts in Denmark and Ireland

Relenza company reaches out to extend pipeline

Action Shares

Novartis launches US $200M ad campaign for Prevacid

The cost of clean hands rocks Toronto City Hall
PTV News: Nov 11, 2009
Top stories on November 11th, 2009:

BMS's billion dollar rheumatoid arthritis deal

Sanofi expands antibody deal with Regeneron

Astellas signs asian licensing deal with Ironwood

Action Shares

1930's STD drug shows late promise for cancer

Adventure capital: Excalibur's plans for the future

CEOs "the most persuasive" at product endorsement
PTV News: Nov 10, 2009
Top stories on November 10th, 2009:

R&D rationalisation: Pfizer closes sites and slashes jobs

Enzon sells off speciality pharma business

Indian generics circle Lipitor

Action shares

Ranbaxy's issues with FDA will take "a long time" to resolve

Merck Serono Ventures seeks early stage biotechs for investment

The genetic factors which can give you a pot belly
PTV News: Nov 9, 2009
Top stories on November 9th, 2009:

Lilly aims to "regain trust" of the public

Walking into Sweden: Boots' bid for Apoteket chain

Rare skin cancer drug gets FDA approval

Potential treatment for Spinal Muscular Atrophy

Mapping the human genome on the cheap

Pfizer's rat ad investigated after viewers' complaints
PTV News: Nov 6, 2009
Top stories on November 6th, 2009:

Biovitrum merges with Swedish Orphan

Vectibix fails secondary endpoint in clinical trial

Prevnar pulled: infant deaths force Pfizer vaccine withdrawal

Small Cap success: Bailard investments at Ausbiotech

WHO: swine flu not becoming drug resistant

UOT study: green tea prevents oral cancer
PTV News: Nov 5, 2009
Top stories on November 5th, 2009:

Merck complete Schering-Plough merger

Novartis buys Chinese vaccine maker

BioPad’s Joe Mosala Molete on South African biotech

Pfizer on partnering: Doug Giordano at BioEurope 2009

New trial for Merck KGaA Stimuvax

Golf: is snoring bad for your handicap?
PTV News: Nov 4, 2009
Top stories on November 4th, 2009:

J&J slash 7% of their workforce

'VIIV': Glaxo and Pfizer launch HIV joint venture

Australian IP case leaves universities on back foot

Eli Lilly's vision for the future: Gino Santini at BIO-Europe 2009

Big pharma faces flu vaccine price fixing investigation

Pensions boost for pharma execs
PTV News: Nov 3, 2009
Top stories on November 3rd, 2009:

Novartis invests US$ 1B in China R&D plant

Anaemia drugs: Amgen's Aranesp doubles stroke risk

Teva Q3: Net Sales up 25%

Roches partnering vision:  Dan Zabrowski at BioEurope 2009

FDA approval for standalone Byetta: stronger labels required

Sleepy teens: lie-ins prevent adolescent obesity
PTV News: Nov 2, 2009
Top stories on November 2nd, 2009:

Benlysta blockbuster? Glaxo Lupus drug passes phase 3s

Takeda sign up Amylin in US$ 1B obesity pact

Risk share deal for Eisai and Quintiles

Rambaxy sells off Vietnam business

Amicus and Shire end ‘lysomal storage disorder’ pact

Fizzy diet drinks – risk of kidney decline
PTV News: Oct 30, 2009
Top stories on October 30th, 2009:

Biotech IPO - can Aldagen float despite losses?

Richter/Forest antipsychotic posts good results

Statins: new evidence they can help you survive flu

Transcept to pay dearly for FDA thumbs down of Intermezzo

Australia set to lift ban on animal-human transplants

Guitar hero seeks pain relief in stem cells
PTV News: Oct 29, 2009
Top stories on October 29th, 2009:

Emerging markets and swine flu ramp GSK profits

Sanofi's cancer deal with Micromet

Vertex Hep C drug boasts impressive trial results

Tysabri test for PML risk

Training med students: the latest inventions from Ausbiotech 2009 

Revealed: a genetic link to bad driving
PTV News: Oct 28, 2009
Top stories on October 28th, 2009:

Astellas' investment in promising prostate cancer candidate

AusBiotech 2009: a sector bouncing back

"Green shoots" as companies start hiring again

Swine flu vaccine shortage: a boost for BioCryst?

Chronic kidney disease - could Shire catch Genzyme?

Pharma-espionage: claims that someone's spying on government drug secrets
PTV News: Oct 27, 2009
Top stories on October 27th, 2009:

Glaxo's US$ 2B gamble pays off as Arzerra gets FDA approval

Approval for anti-anthrax drug stalled

Shire's Vyvance exclusivity confirmed

HPV vaccine survey makes interesting reading for pharmacos

Big pharma borrows from car makers to drive efficiency

Therapeutic Poppy farmers hit by global warming
PTV News: Oct 26, 2009
Top stories on October 26th, 2009:

Lobbying to  save The Medicines Company US$1B

Novo Nordisk's surprise obesity drug

Alcon eyes Potentia in macular degeneration deal

Pfizer's hunt for Indian partners

Vaccine market "worth  US$17B"

Stem cell pioneer sentenced for fraud
PTV News: Oct 23, 2009
Top stories on October 23rd, 2009:

Healthymagination - the US$ 250M healthcare fund from General Electric

Russia's growing pharmaceuticals market

Lost in transmission - is drug labelling misleading?

Novartis faces US$100M sex discrimination case

Gene transfer therapy for Parkinson's

A spoonful of polyethylene: the gel that could give Julie Andrews her voice back
PTV News: Oct 22, 2009
Top stories on October 22nd, 2009:

Novartis bullish with or without vaccine windfall

Mixed results from diabetes trials

Self-service Herceptin to save money, time and stress

The Middle East's emerging market

GeekBook: social networking for scientists

PTV News: Oct 21, 2009
Top stories on October 21th, 2009:

Price war as GSK and Merck go head to head with cancer vaccines

Roche sues Credit Suisse over "risky bonds"

Unigene spawns Tarsa to take forward phase III oral Calcitonin

Tysabri questions: Biogen admits it can be more dangerous over time

Merck joins the transparency trail over doc-disclosure

Internet use boosts elderly brains, high protein diet shrinks them

PTV News: Oct 20, 2009
Top stories on October 20th, 2009:

Roche products re-branded Genentech in US

Lonza drops US$ 460m bid for Patheon

Boehringer's Micardis gets CVD sales boost

AstraZeneca staff to "self-identify" themselves for redundancy

Rare metals to take on cancer

A placebo that hurts for double blind trials

PTV News: Oct 19, 2009
Top stories on October 19th, 2009:

Gardasil and Cervarix - the battle of the cancer vaccines

A new indication for AstraZeneca's Crestor

Amgen's denosumab faces FDA approval delay

Spare parts for diseased hearts

"Zombie biotechs" come back from the dead

PTV News: Oct 16, 2009
Top stories on October 16th, 2009:

Closure: the Pfizer-Wyeth effect on jobs and drug discovery

Baxter: strong earnings, flat sales

Going cheap - the big pharmamanufacturing sell-off

Survival of the fittest - the new biotech landscape

World Health Summit "more than just a talking shop"

Alcohol: does a bit of what you fancy do you good?

PTV News: Oct 15, 2009
Top stories on October 15th, 2009:

Tamiflu fuels Roche Q3 success story

Steps forward in MS as Acorda drug pleases FDA advisors

Progenics regains Relistor rights from Wyeth

Phytopharm soars on monkey data

Biosimilar insulin "could steal $US 6B" from brands

The painkiller made from a painful killer

PTV News: Oct 14, 2009
Top stories on October 14th, 2009:

GSK'S move into orphan drugs

Merck's Indian bioscience buyout

J&J results underwhelm the market

Gout chemical "slows Parkinson's progression"

GSK nurtures talent on doorstep

The "billion dollar market" for CareBots

PTV News: Oct 13, 2009
Top stories on October 13th, 2009:

Onyx aims for the top in Oncology

Lupin's generic birth pills spark patent suits

Novartis in transatlantic deals spree

NICE work - the UK's healthcare watchdog goes international

Imagine - how guided imagery can ease a child's pain

PTV News: Oct 12, 2009
Top stories on October 12th, 2009:

In the genes: why Tamoxifen doesn't always work

Health concerns disrupt Pfizer's lung cancer trials

Cholera vaccine "cheap, safe and effective"

Liver failure antidote good all-rounder

Innovations in cancer: the word from the top

Bug splatter: helping biologists manage research

PTV News: Oct 9, 2009
Top stories on October 9th, 2009:

Novartis hopes for MRSA blockbuster

Omeros joins IPO stream

GSK and Roche in patent battle

Glaxo eyes stake in Dr Reddy's

Australia's biotec surge

More gyms, less sugar - big pharma's recipe for healthcare reform

PTV News: Oct 8, 2009
Top stories on October 8th, 2009:

Blockbuster hopes for Pfizer's HIV drug

"Faithless servant" billed for US$7M

New MS uses for Copaxone

FDA's safety list revealed

New treatment claims for autism

Liquorice warnings for pregnant women

PTV News: Oct 7, 2009
Top stories on October 7th, 2009:

Big pharma raided over generics allegations

GSK's swine flu bonanza

SurModics' US$ 200M deal with Roche

Diabetics boom on the way

Pharma's doubts about drug addiction vaccines

Gene manipulation on the cheap

PTV News: Oct 6, 2009
Top stories on October 6th, 2009:

Sanofi launch generic of their own drug Plavix

Trimeris sold to Arigene for $81M

Sandoz CEO: 10 new drugs a year in Japan

CBR Pharma Insights on ‘lifecycle management’

Glaxo’s Votrient gets FDA advisory thumbs up

Nobel prize for telomerase trio

PTV News: Oct 5, 2009
Top stories on October 5th, 2009:

BMS Dapagliflozen aces phase III

Potential RVO indication for Lucentis

Novel intracellular drug delivery system

Healthcare’s ‘perfect storm’ part 2

Nasal spray to improve memory

PTV News: Oct 2, 2009
Top stories on October 2nd, 2009:

Actavis generic challenge to Pfizer's Lipitor

Talecris IPO exceeds expectations

QLT sells US business to Tolmar

New treatments for ulcerative colitis

Healthcare's "perfect storm"

Allergan pleads the First Amendment

PTV News: Oct 1, 2009
Top stories on October 1st, 2009:

Sanofi still on the prowl for acquisitions

FDA enforcers go after pharma bosses

FDA delays Cervarix decision

IPO revival goes east with Glenmark

Vertex's dash for cash

Why female fruit flies skip their siesta

PTV News: Sep 30, 2009
Top stories on September 30th, 2009:

Boston pays up to settle J&J stent suits

Silence's secret suitor for reverse takeover

FDA delays Cervarix decision

Valeant cuts financial burden to move forward

High hopes for testosterone lotion

MRI scans plot fear in filmgoers' brains

PTV News: Sep 29, 2009
Top stories on September 29th, 2009:

Sacked - Sequenom's top management team goes after trials mishandled

GSK's innovative US$2.2B vaccine deal with Brazil

Atacicept fails again

Avastin's heart failure set-back

Child's death follows Cervarix vaccination

How beating the pine beetle helps cancer research

PTV News: Sep 28, 2009
Top stories on September 28th, 2009:

Abbott buys Solvay's pharma unit

J&J enter flu vaccine fray with stake in Crucell

Novo Nordisk to expand workforce in India

Januvia and Janumet get EMA thumbs up

The green business of biotechnology

ADHD drugs "cut violent crime"

PTV News: Sep 25, 2009
Top stories on September 25th, 2009:

Shock failure of Chelsea's hypotension drug

Pfizer and Eisai make it up

Strategic Alliances Conference - the latest on deals and deal-making

FDA confirms knee device approval was flawed

Management teams "poorly valued" by investors

Genetic cure for burping sheep

PTV News: Sep 24, 2009
Top stories on September 24th, 2009:

Billion dollar buy-back: Leo deal with Warner Chilcott

Bidding war - now Abbott makes an offer for Solvay's drugs unit

Controversy over Erbitux survival rates

Genzyme contamination: plant re-opens but drugs delayed

What happens when the market gets it wrong

Medical maggots: ancient treatment makes a comeback

PTV News: Sep 23, 2009
Top stories on September 23rd, 2009:

Tysabri troubles: two more brain infection cases bring market warning

Personalised medicine goals drive Qiagen purchase of DxS

Glaxo boosts CME transparency

Learning to walk again; big steps in spinal cord injury research

"Greenwash" - does big pharma do enough for the environment?
PTV News: Sep 22, 2009
Top stories on September 22nd, 2009:

Amgen's denosumab gains on Novartis's Zometa

Aspirin indicated for cancer prevention

AstraZeneca and Nektar in 'deal worth US$1.5B'

Pills with microchips aid prescription compliance>

Gene therapy on the way for dieters
PTV News: Sep 21, 2009
Top stories on September 21st, 2009:

Nycomed's US$6B bid for Solvay's drugs unit

Prostate cancer gene breakthrough

Researcher 'killed by plague bacteria'

India pharma on hiring spree

Doing deals a different way

How magnetism can deliver drugs more effectively
PTV News: Sep 18, 2009
Top stories on September 18th, 2009:

Dr Reddy's shares surge on Glaxo stake rumours

FDA label approval "doesn't protect pharma from lawsuits"

Rituxan to be filed for follicular lymphoma

Arena obesity drug swells share price

Fears that slow Healthcare reform will stall recovery

Revealed - the gene that means you need less sleep
PTV News: Sep 17, 2009
Top stories on September 17th, 2009:

Four swine flu vaccines approved in one day

Is the latest IPO a return to the casino?

Axygen and Corning join forces

Gout sufferers and Savient get Kristexxa boost

The tipping point that could spell disaster for big pharma

Gene therapy cure for colour blindness
PTV News: Sep 16, 2009
Top stories on September 16th, 2009:

Novartis hopes for COPD blockbuster

Bayer's new boss announced

Bristol Myers sells Asian assets to Taisho

Europe pumps millions more into drug discovery
New advances in treatment of AIDS/HIV

Boehringer trousers US$100,000 thank you cheque
PTV News: Sep 15, 2009
Top stories on September 15th, 2009:

Eli Lilly aims to save $US1B by cutting 5,500 jobs

Big pharma flunks AIDS/HIV report cards

Alcon eyes ESBATech for US$589M

Patrick Swayze dies from pancreatic cancer as new drug fails

Theravance gets MRSA approval after 12 years

Mellow melons fight stress
PTV News: Sep 14, 2009
Top stories on September 14th, 2009:

Price-cutting: why J&J wants to pay less for Elan

The year's biggest IPO: Talecris plans to raise more than US$800m

The good and the bad for Merck Serono

Medgenics groundbreaking biopump technology

And snorting stem cells: how the nose could be the door to the brain
PTV News: Sep 11, 2009
Top stories on September 11th, 2009:

New claims that Tysabri causes fatal brain disease

Gaucher windfall for Shire

PPI cancer fears allayed

Abbott buys cardiac device company

Sequencing a genome for US$5000

LEDs and tea - a cure for wrinkles?
PTV News: Sep 10, 2009
Top stories on September 10th, 2009:

Potential blockbuster obesity drug for Vivus

Billion dollar Botox bonus

Bouncing back - how a small biotech survived the crash

Pharma reaction to Obama healthcare speech

Gardasil and Cervarix go head to head

Bleaching Jacko: the King of Pop's favourite skin whitener
PTV News: Sep 9, 2009
Top stories on September 9th, 2009:

NICE rejects Bayer's liver cancer drug

European approval for Merck's diabetes innovation

Biogen and Facet fall out over takeover

The highs and lows of NASDAQ biotechs

Cell buys Alpha Innotech

Viva Viagra - but Pfizer doesn't get the joke
PTV News: Sep 8, 2009
Top stories on September 8th, 2009:

The new man at the helm of Roche's drugs division

Hopes raised for an HIV vaccine

Bayer's deal with Noway's Algeta

Obama's make or break speech on healthcare reform

Fat bellies and small moles speed stem cell research
PTV News: Sep 7, 2009
Top stories on September 7th, 2009:

Sinopharm's one billion dollar flotation

Unlicensed Relenza saves woman's life

New Alzheimer's genes identified

Biogen offers less for Facet

New drug "cuts protracted labour"
PTV News: Sep 4, 2009
Top stories on September 4th, 2009:

The weed that sealed a US$287m deal

Shire gets FDA approval for ADHD drug

Elan loses Biogen court case

MabThera goes from strength to strength

How pharma deals are evolving

Why fat thighs may protect you from an early death
PTV News: Sep 3, 2009
Top stories on September 3rd, 2009:

Japan goes west as Dainippon Sumitomo buys Sepracor

PTC's GEMS dazzle Roche

India rejects patent protection for Gilead’s HIV drug

Double vision as Abbot buys Visiogen

GSK takes on the FDA

Four-legged duck helps research into genetic mutation
PTV News: Sep 2, 2009
Top stories on September 2nd, 2009:

Pfizer set to pay US$2.3 B to settle charges of illegal drugs promotion

Biovail Parkinson's psychosis drug fails

FDA says E-cigarettes not safe afterall
PTV News: Sep 1, 2009
Top stories on September 1st, 2009:

Merck re-structuring...

Brilinta the blockbuster drug for AstraZeneca?

Lonza sells plant in Singapore to Genentech

Boehringer’s Pradaxa beats Warfarin

Glaxo makes up for shortages of hib vaccine with Hiberix
PTV News: Aug 31, 2009
Africa Healthcare Special

UNICEF provides community based therapeutic feeding and monitoring centres to improve childrens' health.

How genetically modified crops could provide a solution to poverty.

To watch the full interview with Dr Florence Wambugu (CEO of Africa Harvest Biotech Foundation), click here.
PTV News: Aug 28, 2009
Top stories on August 28th, 2009:

Abbott and Pfizer join forces to combat lung cancer

How a major charity is helping big pharma with clinical trials

And getting nasty - Pfizer's row with Venezuela escalates
PTV News: Aug 27, 2009
Top stories on August 27th, 2009:

Did Nymox jump the gun with their liver cancer claims?

Colon cancer caused by a bug?

EU and US R&D battle

Japanese Korean prodigy - PhD aged 19
PTV News: Aug 26, 2009
Top stories on August 26th, 2009:

NICE says no to cancer drugs funding

Roche says obesity drug is safe

GSK rumoured to be interested in HGS takeover bid worth $4 billion

Married people the most likely to survive cancer?
PTV News: Aug 25, 2009
Top stories on August 25th, 2009:

FDA Approves Lunbeck's drug for infantile spasms

RNA specialist Santaris forms an alliance with Shire

Asthma drug Xolair given EU approval

Valeant's drug for shingles fails

A small Veterinary pharmacy attempts to derail Pfizer-Wyeth Deal
PTV News: Aug 24, 2009
Top stories on August 24th, 2009:

The $3 billion price tag for Proctor and Gamble’s prescription drug business

How much is Patheon worth? Lonza bids 460 million Dollar.

Combining cell therapy and gene therapy to provide a new type of personalised medicine
PTV News: Aug 21, 2009
Top stories on August 20th, 2009:

Will AstraZeneca hit the jackpot with MedImmune’s Flumist?

Big pharma wins indian patent decision

Pfizer looks at Facebook model to boost clinical trial

FDA approves GlaxoSmithKline’s Hiberix

New studies on cancer drugs shows personalised medicine is the way forward
PTV News: Aug 20, 2009
Top stories on August 20th, 2009:

Glenmark’s new drug fails test

Merck makes deal with Covance

Big Pharma to pay NIH?

Deal trends in oncology

FDA approves Extavia (Novartis)
PTV News: Aug 19, 2009
Top stories on August 19th, 2009:

GSK and Genmab hit by disappointing cancer drug trials

Roche’s AVASTIN goes from strength to strength

How British Biotechs hope to benefit from a government innovation fund

The quest for eternal youth and huge profits: tests begin on anti-ageing drugs.


To watch this programme, please Log in or Register.
PTV News: Aug 18, 2009
Top stories on August 18th, 2009:

NICE drives a hard bargain before giving J&J’s psoriasis treatment the go-ahead

India’s pharma-outsourcing industry is set to double by the end of next year…so what other opportunites are there in the sub-continent.

Sanofi sees of a generics challenge to ELOXATIN.

And the gene which determines if modern medicines can cure your Hepatitis C


To watch this programme, please Log in or Register.
PTV News: Aug 17, 2009
Top stories on August 17th, 2009:

Optimism breaks out among biotech investors. But is it based on reality or wishful thinking?

Shortening the odds of cancer – why tall men are more at risk.

And yet another good reason to eat chocolate: new research shows it can help you survive a heart attack


To watch this programme, please Log in or Register.
PTV News Promo

On Monday, 17th August, PharmaTelevision launches PTV News, a dynamic daily programme covering the business of healthcare.

Incorporating news stories from around the world, expert analysis and informed comment, PTV News provides in-depth insight on breaking stories to help you stay ahead of the fast moving developments and trends in our exciting business sector.

PTV News is available to subscribers of PharmaTelevision Premium Content.
 
 
© 2009 Rx Celebs, LLC